Pulmozyme Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Pulmozyme to Improve COVID-19 ARDS Outcomes
Condition:   COVID Interventions:   Drug: Pulmozyme;   Drug: Placebo Sponsors:   Boston Children’s Hospital;   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials

Dornase Alfa for ARDS in Patients With SARS-CoV-2
Conditions:   SARS-CoV 2;   ARDS Intervention:   Drug: Dornase Alfa Inhalation Solution Sponsor:   University of Missouri-Columbia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2020 Category: Research Source Type: clinical trials